Edit

Gameto

https://gametogen.com/

Last activity: 10.07.2026

Active

Categories: BioTechFemTechHealthcareIVFStemCells

We are a biotechnology company dedicated to understanding and eliminating infertility and menopause, by leveraging a mix of computational processes and cellular reprogramming technology.

Followers

611

Followers

305

Website visits

7.3K /mo.

Mentions

Location: United States

Employees: 11-50

Total raised: $117M

Founded date: 2020

Twitter

Investors 10

Date	Name	Website
12.06.2022	Yes VC	yes.vc
-	Myelin VC	myelin.vc
-	Solari Cap...	solaricap....
07.11.2023	Future Ven...	future.ven...
26.09.2022	Insight Pa...	insightpar...
11.01.2022	Lux Capita...	luxcapital...
05.07.2022	Plum Alley...	plumalley....
23.12.2024	Overwater ...	overwater....
05.09.2022	For Good V...	forgoodven...
10.07.2026	Ingeborg I...	ingeborgin...

Funding Rounds 4

Date	Series	Amount	Investors
12.08.2025	Series C	$44M	RA Capital...
31.05.2024	Series B	$33M	-
14.09.2022	-	$17M	-
11.01.2022	Seed	$23M	-

Mentions in press and media 28

Date	Title	Description
05.05.2026	Deviation Capital Launches With $2 Billion In AUM Following Spinout From Two Sigma	Deviation Capital, an early-stage venture capital firm, has launched as a newly independent business following the completed spinout of the Two Sigma Ventures operation from quantitative investment and trading firm Two Sigma. As part of the...
12.08.2025	FemTech: Gameto Secures $44M to Advance Stem Cell Therapy for Infertility and Menopause	What You Should Know: – Gameto, a clinical-stage biotechnology company focused on reproductive health secures $44M in Series C funding, bringing its total capital raised to a leading $127M. – The funding, led by Overwater Ventures with part...
12.08.2025	Gameto Raises $44M in Series C Funding	Gameto, an Austin, TX-based clinical-stage biotechnology company developing stem cell-derived therapies for reproductive health, raised $44M in Series C funding. The round was led by Overwater Ventures, with participation from Insight Partn...
12.08.2025	Gameto Closes $44M Series C Round	AUSTIN, TX, Gameto, a clinical-stage biotechnology company developing stem cell-derived therapies for reproductive health, today announced the completion of a $44 million Series C financing round. >> Click here for more funding data ...
06.06.2024	Gameto Secures $33M in Series B Funding to Transform Fertility Treatments	In a bold move that is set to revolutionize the fertility market, Gameto, a cutting-edge biotechnology company headquartered in New York City, has successfully raised $33 million in Series B funding. This significant investment, spearheaded...
31.05.2024	Gameto Raises $33M to Use Cell Engineering to Revolutionize Fertility Treatments	When accounting for IVF, genetic testing, donor services, and reproductive tissue storage, the fertility market in the US is estimated to be more than $8B One in five individuals struggle to conceive, and yet only 2% of newborns are conceiv...
29.05.2024	Gameto Raises $33M in Series B Funding	Gameto, a NYC-based biotechnology company dedicated to advancing treatment options in women’s health, raised $33M in Series B funding. The round, which brought the total amount to $73M, was led by Two Sigma Ventures and RA Capital with part...
29.05.2024	Gameto Banks $33 Million in Series B	NEW YORK, NY, Gameto, a biotechnology company dedicated to advancing treatment options in women's health, has closed an oversubscribed $33 million Series B financing round. >> Click here for more funding data on Gameto >> To ex...
23.04.2024	Gameto Partners with Designer and Entrepreneur Stacey Bendet to Launch "Your Eggsperience Matters" Campaign to Raise Funds for RESOLVE During National Infertility Awareness Week	Campaign spotlights systemic healthcare issues women experience NEW YORK, April 23, 2024 /PRNewswire/ -- Gameto, a female-led biotechnology company with a mission to redefine women's healthcare, today announced they are joining forces with ...
21.05.2023	Unlocking the trillion-dollar female economy	Monique Woodard Contributor Share on Twitter Monique Woodard is the founder and managing director of Cake Ventures. As women have gained economic power, their economic influence has expanded. Women long held primary purchasing responsibilit...
29.01.2023	From Jeff Bezos to Jack Dorsey, here are 14 the world's wealthiest entrepreneurs trying to crack the code of living forever	Jeff Bezos is one among a handful of billionaires working to rewind the clock. Gareth Cattermole / Staff/ Getty Images A growing number of the world's richest entrepreneurs are using their wealth to fight aging. They're taking supplements, ...
07.12.2022	A healthcare brand for women begins to take shape	Until last year, healthcare funding continued to shatter previous records. But there remains at least one very big hole in the industry. No one has yet created a broad, leading women’s healthcare brand, and that spells opportunity. Dina Rad...
20.09.2022	Ukrainian TA Ventures participates in a $17M round of biotech Gameto	Ukrainian TA Ventures participates in a $17M round of biotech Gameto 20 September, 2022, 11:11 Lisa Palchynska --> --> --> -->--> --> --> --> --> --> --> --> --> Ukrainian venture capital fund TA Ve...
16.09.2022	Gameto Raises Additional $17M in Funding	Gameto, a NYC- and Madrid, Spain-based biotechnology company using cell engineering to develop therapeutics for diseases of the female reproductive system, raised an additional $17m in funding. Backers included Insight Partners, Future Vent...
14.09.2022	Using cell engineering to cure female reproductive diseases, Gameto raises $17M	The company raised a $23 million round of funding in January Common reproductive health concerns for women include endometriosis, which is when the kind of tissue that normally lines the uterus grows on the ovaries, behind the uterus, on th...
27.07.2022	Elon Musk’s Babies Were Conceived Via IVF And Surrogacy - Is It The Future Of Reproduction?	Vitro Fertilization. IVF and Human fetus with DNA strand. 3d illustration getty
19.05.2022	Can We Fix Ovarian Aging? Here Is One Startup Up For The Task!	Concept of a healthy female reproductive system. getty
11.01.2022	Femtech startup Gameto lands $20M	Gameto has raised a $20 million Series A led by Future Ventures. The New York-based company is developing ovarian therapeutics intended to improve fertility and help women manage the impact of menopause. Select Additional Investors Bold Cap...
10.01.2022	Gameto Raises $23M in Seed and Series A	NEW YORK, NY, Gameto, a biotechnology start-up, has raised a $20 million in Series A funding led by Future Ventures. >> Click here for more funding data on Gameto >> To export Gameto funding data to PDF and Excel, click here...
10.01.2022	Gameto Raises $23M in Funding	Gameto, a NYC- and Boston, MA-based biotechnology startup solving the problem of accelerated ovarian aging to change the trajectory of women’s health and equality, raised a $20m Series A funding. The round was led by Future Ventures, with p...
10.01.2022	Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells	NEW YORK, Jan. 10, 2022 /PRNewswire/ -- Gameto, a biotechnology start-up solving the problem of accelerated ovarian aging to change the trajectory of women's health and equality, today announced that it has raised a $20 million in Series A ...
10.01.2022	With funding from top investors, Gameto aims to delay — even eradicate — menopause	With every year, more scientists and academics are very specifically trying to lengthen the lifespan of humans and ensure that those extra years are worth living. Some of these teams are focused on detecting cancer earlier as a means of ext...
10.01.2022	Gameto Raises $23M in Funding	Gameto, a NYC- and Boston, MA-based biotechnology startup solving the problem of accelerated ovarian aging to change the trajectory of women’s health and equality, raised a $20m Series A funding.
-	Top Tech Journalists Shaping LA’s Tech Scene in 2024 🤝 Venture Deals 🤝 Venture Deals 🤝 Venture Deals 📅 LA Tech Calendar 📙 What We’re Reading	🔦 Spotlight Image Source: Business Insider BEN BERGMAN Ben is currently a senior correspondent at Business Insider, where he covers the intersection of technology and business. Based in Los Angeles, Ben writes in depth pieces on the latest ...
-	Gameto	“Gameto is a new breed of biotechnology company in female reproductive longevity”
-	Gameto	“Redefining female reproductive health.”
-	Gameto	“Breaking Barriers in Women's Health with Gameto's Biotechnology Innovations. Explore how we are transforming fertility treatments and menopause care.”
-	Ovarian Aging Solutions Company Gameto Secures $23 Million	Gameto recently announced it raised $23 million in funding. These are the details. Gameto — a biotechnology start-up solving the problem of accelerated ovarian aging to change the trajectory of women’s health and equality — recently announc...

Gameto

Investors 10

Funding Rounds 4

Mentions in press and media 28

Reviews 0